Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Field Trip Health & Wellness Ltd. FTHWF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
43/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Field Trip Health & Wellness Ltd. (FTHWF) is a Biotechnology company in the Healthcare sector, currently trading at $0.04. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $48M (loss), growing at -301.6%/yr. Net profit margin is 0% (thin). Gross margin is -88.3% (+752 pp trend).

Balance sheet: total debt is $3M against $21M equity (Debt-to-Equity (D/E) ratio 0.16, conservative). Current ratio is 3.52 (strong liquidity). Debt-to-assets is 11.3%. Total assets: $30M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 15/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

FTHWF SharesGrow Score Overview

58/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 15/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — FTHWF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
FTHWF: +32098.4%/yr revenue is, -301.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet FTHWF: Debt-to-Equity (D/E) ratio 0.16 (conservative), Current ratio is 3.52 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
15/100
FTHWF: Gross margin is -88.3% (+752 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 15/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0177-0.5
Volume86.27K
Avg Volume (30D)10.69K
Market Cap$3.71M
Beta (1Y)0.00
Share Statistics
EPS (TTM)-4.17
Shares Outstanding$11.64M
IPO Date2022-08-18
CEORonan Levy
Financial Highlights & Ratios
EBITDA$-17.15M
Net Income$-48.49M
Operating Income$-20.37M
Total Cash$27.2M
Total Debt$3.37M
Net Debt$-23.83M
Total Assets$29.74M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA31656Q1046

Price Chart

Track all markets on TradingView
FTHWF
Field Trip Health & Wellness Ltd. ↗  ·  Other OTC
Healthcare • Biotechnology
0.02 52WK RANGE 0.50

People Also View

TLPPF
TLPPF
Telix Pharmaceuticals Limited
$10.50
-2.78%
 ROIVW
ROIVW
Roivant Sciences Ltd.
$2.75
+4.56%
 GHRS
GHRS
GH Research PLC
$17.00
+1.37%
 NAUT
NAUT
Nautilus Biotechnology, Inc.
$3.25
+6.21%
 CMVLF
CMVLF
Cellectis S.A.
$3.08
-30.00%
 MAIA
MAIA
MAIA Biotechnology, Inc.
$1.42
+3.65%
 SABS
SABS
SAB Biotherapeutics, Inc.
$4.05
+4.92%
 IGC
IGC
India Globalization Capital, Inc.
$0.32
+3.19%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message